Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Diamond

Concepts (351)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
16
2024
218
6.020
 Why?
Breast Neoplasms
27
2026
2393
4.210
 Why?
Antineoplastic Agents
23
2023
2219
2.350
 Why?
Immunoconjugates
7
2023
138
2.330
 Why?
Antineoplastic Combined Chemotherapy Protocols
20
2025
1969
2.210
 Why?
Pyrimidines
9
2021
530
2.160
 Why?
Protein Kinase Inhibitors
11
2025
981
1.680
 Why?
Piperazines
5
2023
375
1.570
 Why?
Paclitaxel
6
2022
259
1.470
 Why?
Camptothecin
9
2023
138
1.460
 Why?
Neoplasms
15
2026
2913
1.450
 Why?
Pyrazoles
6
2021
517
1.230
 Why?
Ovarian Neoplasms
5
2025
595
1.220
 Why?
Quinoxalines
2
2020
65
1.210
 Why?
Azepines
3
2020
105
1.140
 Why?
Histone Deacetylase Inhibitors
4
2024
218
1.110
 Why?
Antibodies, Monoclonal, Humanized
10
2024
992
1.110
 Why?
Cyclin-Dependent Kinase 4
2
2018
53
1.000
 Why?
Cyclin-Dependent Kinase 6
2
2018
49
1.000
 Why?
Carcinoma, Lobular
3
2026
56
0.840
 Why?
Neutropenia
4
2022
154
0.810
 Why?
Benzoxazoles
2
2021
20
0.800
 Why?
Xenograft Model Antitumor Assays
12
2026
936
0.730
 Why?
Gene Expression Regulation, Neoplastic
5
2020
1450
0.720
 Why?
Maximum Tolerated Dose
10
2026
211
0.690
 Why?
Breast Neoplasms, Male
2
2018
29
0.680
 Why?
beta Catenin
2
2020
254
0.680
 Why?
Female
59
2026
79025
0.660
 Why?
Receptors, Estrogen
3
2021
404
0.630
 Why?
Chemotherapy, Adjuvant
4
2023
427
0.630
 Why?
Lymphocytes, Tumor-Infiltrating
2
2020
153
0.630
 Why?
Cancer Care Facilities
1
2020
48
0.620
 Why?
Tumor Microenvironment
5
2026
735
0.600
 Why?
Nuclear Proteins
3
2026
740
0.600
 Why?
eIF-2 Kinase
1
2019
28
0.600
 Why?
Humans
70
2026
145750
0.570
 Why?
Anthracyclines
3
2023
49
0.560
 Why?
Pyridines
5
2025
609
0.560
 Why?
Taxoids
3
2023
114
0.550
 Why?
Aged
27
2026
26212
0.530
 Why?
Aurora Kinase A
4
2020
61
0.520
 Why?
Carcinoma, Ductal, Breast
1
2018
90
0.520
 Why?
Wnt Signaling Pathway
1
2019
212
0.510
 Why?
Drug Resistance, Neoplasm
4
2020
883
0.500
 Why?
Trastuzumab
4
2023
118
0.500
 Why?
Pyrazines
2
2018
94
0.490
 Why?
Aromatase Inhibitors
3
2025
81
0.480
 Why?
Colonic Neoplasms
1
2018
258
0.470
 Why?
Myocardial Infarction
1
2023
1211
0.460
 Why?
Tumor Suppressor Protein p53
4
2024
534
0.460
 Why?
Cell Line, Tumor
11
2026
3551
0.460
 Why?
Angiopoietin-1
1
2015
12
0.450
 Why?
Angiopoietin-2
1
2015
15
0.450
 Why?
Neoplasm Recurrence, Local
5
2025
1150
0.440
 Why?
Neoadjuvant Therapy
1
2018
467
0.430
 Why?
Middle Aged
28
2026
36297
0.400
 Why?
Uterine Cervical Neoplasms
1
2017
268
0.400
 Why?
Medicare
4
2023
904
0.400
 Why?
Bridged-Ring Compounds
2
2023
31
0.390
 Why?
Adult
29
2026
40867
0.380
 Why?
Colorectal Neoplasms
5
2022
868
0.370
 Why?
Dose-Response Relationship, Drug
6
2022
2028
0.370
 Why?
Tumor Suppressor Proteins
1
2015
322
0.370
 Why?
Cell Proliferation
8
2020
2514
0.370
 Why?
Proto-Oncogene Proteins c-met
1
2013
76
0.370
 Why?
Quinolines
4
2025
190
0.370
 Why?
Lung Neoplasms
3
2026
2667
0.370
 Why?
Antibodies, Monoclonal
4
2024
1505
0.360
 Why?
Recombinant Fusion Proteins
1
2015
666
0.360
 Why?
Radiosurgery
3
2025
399
0.360
 Why?
Antineoplastic Agents, Immunological
3
2019
198
0.360
 Why?
Point Mutation
1
2013
241
0.360
 Why?
Treatment Outcome
13
2025
11793
0.360
 Why?
Neoplasm Metastasis
5
2026
688
0.350
 Why?
Triazoles
1
2013
191
0.340
 Why?
Angiogenesis Inhibitors
3
2018
239
0.340
 Why?
Mice, Nude
6
2020
680
0.330
 Why?
Aged, 80 and over
10
2025
8346
0.320
 Why?
Clinical Trials, Phase I as Topic
2
2020
50
0.320
 Why?
Carcinoma, Renal Cell
1
2013
230
0.320
 Why?
Mitochondria
1
2017
992
0.310
 Why?
Heart Failure
1
2023
2326
0.310
 Why?
Histones
3
2023
666
0.310
 Why?
Genes, BRCA2
1
2009
33
0.300
 Why?
Adaptor Proteins, Signal Transducing
2
2026
426
0.300
 Why?
Genes, BRCA1
1
2009
45
0.300
 Why?
Molecular Targeted Therapy
3
2019
440
0.290
 Why?
Biomarkers, Tumor
2
2014
1329
0.290
 Why?
BRCA2 Protein
1
2009
68
0.290
 Why?
Apoptosis
7
2024
2443
0.290
 Why?
Pregnancy Complications, Neoplastic
1
2009
63
0.290
 Why?
Thrombophilia
1
2009
89
0.280
 Why?
Kidney Neoplasms
1
2013
414
0.280
 Why?
Neoplasm Staging
5
2021
1474
0.280
 Why?
Mice
12
2026
18357
0.280
 Why?
Receptors, Progesterone
2
2021
244
0.270
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2026
133
0.270
 Why?
Adenine
2
2021
339
0.270
 Why?
DNA-Binding Proteins
1
2015
1482
0.260
 Why?
Aminopyridines
3
2026
129
0.240
 Why?
Models, Biological
1
2014
1764
0.240
 Why?
Nicotinamide Phosphoribosyltransferase
1
2026
26
0.240
 Why?
Cell Cycle Proteins
3
2026
630
0.230
 Why?
Selective Estrogen Receptor Modulators
1
2025
34
0.230
 Why?
Doxorubicin
3
2024
403
0.220
 Why?
Cardiorespiratory Fitness
1
2025
74
0.220
 Why?
Animals
15
2026
38100
0.210
 Why?
Biopsy
3
2018
1082
0.210
 Why?
Cyclophosphamide
2
2018
272
0.200
 Why?
DNA Repair
1
2026
255
0.200
 Why?
Trans-Activators
1
2026
396
0.200
 Why?
Wound Healing
1
2026
355
0.190
 Why?
Disease Models, Animal
3
2021
4569
0.190
 Why?
Brain Neoplasms
3
2025
1331
0.190
 Why?
Liver Neoplasms
1
2009
777
0.180
 Why?
United States
5
2023
16122
0.180
 Why?
Cyclin-Dependent Kinase 9
1
2022
18
0.180
 Why?
Histone Deacetylase 1
1
2022
23
0.180
 Why?
Aurora Kinases
2
2012
28
0.180
 Why?
G2 Phase Cell Cycle Checkpoints
3
2022
44
0.180
 Why?
Topoisomerase I Inhibitors
2
2022
19
0.170
 Why?
Fluorouracil
1
2022
231
0.170
 Why?
Disease Progression
4
2019
2865
0.170
 Why?
Administration, Oral
3
2022
867
0.170
 Why?
Acetylation
1
2022
259
0.170
 Why?
Androstadienes
1
2021
77
0.170
 Why?
Biliary Tract Neoplasms
1
2021
31
0.160
 Why?
Arrhythmias, Cardiac
1
2023
356
0.160
 Why?
Drug Administration Schedule
3
2017
782
0.160
 Why?
Heterografts
1
2021
143
0.160
 Why?
Carboplatin
1
2021
164
0.160
 Why?
Diarrhea
2
2019
193
0.160
 Why?
Hospitals, University
1
2021
176
0.160
 Why?
Necrosis
2
2019
244
0.160
 Why?
Male
16
2026
72992
0.160
 Why?
Histone Deacetylases
1
2022
207
0.160
 Why?
Cancer Survivors
1
2025
338
0.160
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.150
 Why?
Fatigue
2
2022
365
0.150
 Why?
Immune System
1
2021
180
0.150
 Why?
Immunotherapy
2
2023
667
0.150
 Why?
Clinical Trials as Topic
3
2016
1062
0.150
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
39
0.150
 Why?
Benzodiazepines
1
2021
168
0.150
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
138
0.150
 Why?
Corneal Ulcer
1
1999
20
0.150
 Why?
Kaplan-Meier Estimate
1
2021
971
0.140
 Why?
Tumor Cells, Cultured
1
2020
887
0.140
 Why?
Albumins
1
2019
119
0.140
 Why?
Aquaporin 4
1
2019
101
0.140
 Why?
Maintenance Chemotherapy
1
2018
42
0.140
 Why?
Sucrase
1
1998
2
0.140
 Why?
Vascular Endothelial Growth Factor A
2
2018
552
0.140
 Why?
Cornea
1
1999
154
0.130
 Why?
Microvilli
1
1998
75
0.130
 Why?
Cytokines
1
2026
2069
0.130
 Why?
Nausea
1
2018
112
0.130
 Why?
Mice, Inbred BALB C
1
2020
1261
0.130
 Why?
Drug Therapy, Combination
1
2020
1044
0.130
 Why?
Breast
1
2018
156
0.130
 Why?
Antibodies, Bispecific
1
2018
68
0.130
 Why?
Radiotherapy, Adjuvant
1
2018
222
0.130
 Why?
Purines
1
2018
187
0.130
 Why?
Benzimidazoles
1
2018
189
0.130
 Why?
Topotecan
1
2017
17
0.130
 Why?
Bacterial Infections
1
1999
246
0.130
 Why?
Isoflavones
1
2017
25
0.130
 Why?
Imidazoles
1
2018
247
0.130
 Why?
Calcium-Binding Proteins
1
2018
221
0.130
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
23
0.120
 Why?
Carbolines
1
2017
35
0.120
 Why?
Survival Analysis
1
2020
1378
0.120
 Why?
Inhibitory Concentration 50
2
2016
91
0.120
 Why?
Programmed Cell Death 1 Receptor
1
2019
266
0.120
 Why?
Mastectomy
1
2018
185
0.120
 Why?
Hypertension
2
2018
1276
0.120
 Why?
Cell Survival
1
2019
1103
0.120
 Why?
Insulin-Like Growth Factor I
1
2018
317
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
100
0.120
 Why?
Retrospective Studies
4
2025
17322
0.110
 Why?
GPI-Linked Proteins
1
2016
81
0.110
 Why?
Neoplasms, Second Primary
1
2016
102
0.110
 Why?
Tumor Protein p73
1
2015
18
0.110
 Why?
Antibodies, Neoplasm
1
2015
34
0.110
 Why?
Phosphorylation
1
2019
1708
0.110
 Why?
Risk Reduction Behavior
1
2016
217
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2024
1191
0.110
 Why?
Hodgkin Disease
1
2016
172
0.110
 Why?
Nanoparticles
1
2021
517
0.110
 Why?
Oxazoles
2
2025
48
0.110
 Why?
Maytansine
1
2014
18
0.110
 Why?
Demography
1
2015
282
0.100
 Why?
Brain Edema
1
2014
62
0.100
 Why?
Protein Kinases
1
2015
312
0.100
 Why?
Drug Interactions
1
2015
405
0.100
 Why?
Bacteria
1
1999
766
0.100
 Why?
Survival Rate
2
2019
2094
0.100
 Why?
Threonine
1
2013
44
0.100
 Why?
Exercise
1
2025
2203
0.100
 Why?
Sulfones
1
2014
127
0.100
 Why?
Tumor Stem Cell Assay
1
2012
34
0.090
 Why?
Quinazolines
2
2025
266
0.090
 Why?
Drug Evaluation, Preclinical
1
2013
196
0.090
 Why?
Glycine
1
2014
186
0.090
 Why?
Randomized Controlled Trials as Topic
1
2019
1751
0.090
 Why?
Diabetes Mellitus, Type 2
2
2025
2602
0.090
 Why?
Drug Design
1
2013
175
0.090
 Why?
Methionine
1
2013
161
0.090
 Why?
Time Factors
2
2020
7133
0.090
 Why?
Heterozygote
1
2013
314
0.090
 Why?
Intestinal Mucosa
1
1998
675
0.090
 Why?
Treatment Failure
1
2013
360
0.090
 Why?
In Situ Hybridization, Fluorescence
1
2013
328
0.090
 Why?
Disease-Free Survival
1
2014
770
0.090
 Why?
Analgesics, Opioid
1
2021
1154
0.090
 Why?
Neovascularization, Pathologic
1
2013
287
0.090
 Why?
Cell Transformation, Neoplastic
1
2013
337
0.080
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
231
0.080
 Why?
Cluster Analysis
1
2012
501
0.080
 Why?
Carcinoma in Situ
1
2011
44
0.080
 Why?
Computational Biology
1
2015
669
0.080
 Why?
Risk Assessment
1
2020
3752
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
86
0.080
 Why?
Risk Factors
2
2025
10916
0.080
 Why?
Colorado
1
2020
4556
0.080
 Why?
Cellular Senescence
1
2012
226
0.080
 Why?
Sequence Analysis, DNA
1
2013
778
0.080
 Why?
Mutation
2
2012
4090
0.080
 Why?
Gastric Emptying
1
2009
36
0.070
 Why?
Tumor Burden
1
2010
325
0.070
 Why?
Keratinocytes
1
2010
249
0.070
 Why?
Pregnancy Trimester, Second
1
2009
84
0.070
 Why?
Enteric Nervous System
1
2009
26
0.070
 Why?
Stomach
1
2009
111
0.070
 Why?
Mastectomy, Segmental
1
2009
107
0.070
 Why?
Pregnancy Trimester, First
1
2009
139
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
187
0.070
 Why?
Muscle, Smooth
1
2009
153
0.070
 Why?
Lymph Node Excision
1
2009
173
0.070
 Why?
Diabetes Mellitus, Experimental
1
2009
199
0.070
 Why?
Risk
1
2009
923
0.060
 Why?
Cell Adhesion Molecules
2
2019
181
0.060
 Why?
Infusions, Intravenous
2
2019
428
0.060
 Why?
Pentosyltransferases
1
2026
7
0.060
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 4
1
2026
15
0.060
 Why?
Antigens, Neoplasm
2
2019
271
0.060
 Why?
Phosphodiesterase 4 Inhibitors
1
2026
12
0.060
 Why?
Prognosis
2
2018
4329
0.060
 Why?
Cyclopropanes
1
2026
84
0.060
 Why?
Acrylamides
1
2026
74
0.060
 Why?
Gene Expression Profiling
1
2012
1777
0.060
 Why?
Phthalazines
1
2026
63
0.060
 Why?
Cyclic AMP Response Element-Binding Protein
1
2026
146
0.060
 Why?
CD8-Positive T-Lymphocytes
2
2023
923
0.050
 Why?
Alveolar Epithelial Cells
1
2026
121
0.050
 Why?
Benzamides
1
2026
226
0.050
 Why?
Accelerometry
1
2025
118
0.050
 Why?
Cell Cycle
2
2018
599
0.050
 Why?
Combined Modality Therapy
2
2019
1270
0.050
 Why?
Mesylates
1
2022
7
0.050
 Why?
Follow-Up Studies
2
2025
5428
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
69
0.050
 Why?
Signal Transduction
2
2014
5223
0.050
 Why?
Oxygen Consumption
1
2025
719
0.050
 Why?
Clinical Protocols
1
2023
280
0.040
 Why?
Ligands
1
2024
668
0.040
 Why?
RNA, Small Interfering
1
2024
638
0.040
 Why?
Chimerism
1
2021
35
0.040
 Why?
Lymphocyte Subsets
1
2021
78
0.040
 Why?
Lymphoid Tissue
1
2021
78
0.040
 Why?
Blood Glucose
3
2025
2344
0.040
 Why?
Liver
1
2009
1899
0.040
 Why?
Mice, SCID
1
2021
369
0.040
 Why?
Hormones
1
2020
135
0.040
 Why?
SEER Program
1
2021
230
0.040
 Why?
Mice, Inbred NOD
1
2021
616
0.040
 Why?
Bacteriological Techniques
1
1999
66
0.040
 Why?
Immunohistochemistry
2
2016
1723
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
23
0.040
 Why?
Monosaccharide Transport Proteins
1
1998
56
0.030
 Why?
Tissue Distribution
1
2018
335
0.030
 Why?
Infant, Newborn
1
2009
6464
0.030
 Why?
Anemia
1
2019
191
0.030
 Why?
Insulin Resistance
1
2025
1244
0.030
 Why?
Intestine, Small
1
1998
167
0.030
 Why?
Biological Transport
1
1998
424
0.030
 Why?
Pregnancy
1
2009
7215
0.030
 Why?
In Vitro Techniques
1
1998
1049
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
106
0.030
 Why?
Cetuximab
1
2016
111
0.030
 Why?
Neoplasm Transplantation
1
2016
246
0.030
 Why?
Retreatment
1
2016
80
0.030
 Why?
Drug Screening Assays, Antitumor
1
2016
194
0.030
 Why?
Platinum
1
2016
48
0.030
 Why?
Carotid Artery Diseases
1
1996
70
0.030
 Why?
Arterial Occlusive Diseases
1
1996
90
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2016
254
0.030
 Why?
History, Ancient
1
2015
53
0.030
 Why?
Transcription Factors
1
2023
1736
0.030
 Why?
C-Peptide
1
1996
190
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
699
0.030
 Why?
Carotid Arteries
1
1996
208
0.030
 Why?
Femoral Artery
1
1996
190
0.030
 Why?
Kinetics
1
1998
1568
0.030
 Why?
Databases, Genetic
1
2015
238
0.030
 Why?
Diabetic Angiopathies
1
1996
265
0.030
 Why?
Biomarkers
2
2016
4302
0.030
 Why?
DNA Damage
1
2017
437
0.030
 Why?
Mice, Knockout
1
2021
3130
0.020
 Why?
Cross-Sectional Studies
1
2025
5921
0.020
 Why?
Quality of Life
1
2025
3210
0.020
 Why?
Phenotype
1
2021
3170
0.020
 Why?
Glucose
1
1998
1048
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
261
0.020
 Why?
Tomography, X-Ray Computed
2
2016
2770
0.020
 Why?
Opioid-Related Disorders
1
2021
605
0.020
 Why?
Drug Combinations
1
2013
396
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
457
0.020
 Why?
Lipids
1
1996
707
0.020
 Why?
Biopsy, Needle
1
2011
185
0.020
 Why?
Proto-Oncogene Proteins
1
2014
625
0.020
 Why?
HT29 Cells
1
2010
37
0.020
 Why?
Enzyme Inhibitors
1
2014
821
0.020
 Why?
Protein-Tyrosine Kinases
1
2013
431
0.020
 Why?
Transcription, Genetic
1
2017
1454
0.020
 Why?
Cohort Studies
1
2021
6032
0.020
 Why?
ErbB Receptors
1
2013
635
0.020
 Why?
Ki-67 Antigen
1
2010
118
0.020
 Why?
Capillary Permeability
1
2010
132
0.020
 Why?
Gastrointestinal Motility
1
2009
29
0.020
 Why?
Patient Selection
1
2013
739
0.020
 Why?
Biological Clocks
1
2009
48
0.020
 Why?
Patient Satisfaction
1
2013
712
0.020
 Why?
Tomography, Emission-Computed, Single-Photon
1
2009
104
0.020
 Why?
Microscopy, Electron
1
2009
414
0.020
 Why?
Membrane Proteins
1
2015
1166
0.020
 Why?
Positron-Emission Tomography
1
2010
343
0.020
 Why?
Rats, Wistar
1
2009
450
0.020
 Why?
Algorithms
1
2015
1850
0.020
 Why?
Magnetic Resonance Imaging
1
2019
3915
0.010
 Why?
Insulin
1
1996
2516
0.010
 Why?
Adolescent
1
2024
22569
0.010
 Why?
Brain
1
2014
2969
0.010
 Why?
Rats
1
2009
5585
0.010
 Why?
Young Adult
1
2014
14250
0.010
 Why?
Tunica Media
1
1996
37
0.010
 Why?
Cholesterol, HDL
1
1996
201
0.010
 Why?
Fasting
1
1996
279
0.010
 Why?
Cholesterol
1
1996
408
0.010
 Why?
Regression Analysis
1
1996
1001
0.010
 Why?
Ultrasonography
1
1996
788
0.010
 Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (351) concept(s)
_
Co-Authors Expand Description
See all (74) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)